, Tracking Stock Market Picks
Enter Symbol:
Apricus Biosciences Inc (APRI) [hlAlert]

Mkt Outperform
down 59.53 %

Apricus Biosciences Inc (APRI) rated Mkt Outperform with price target $6 by JMP Securities

Posted on: Thursday,  Jun 14, 2012  10:25 AM ET by JMP Securities

JMP Securities rated Mkt Outperform Apricus Biosciences Inc (NASDAQ: APRI) on 06/14/2012, when the stock price was $3.04.
Since then, Apricus Biosciences Inc has lost 59.54% as of 11/06/2015's recent price of $1.23.
If you would have followed this JMP Securities's recommendation on APRI, you would have lost 59.53% of your investment in 1240 days.

NexMed, Inc. is a pharmaceutical and medical technology company. They develop and commercialize therapeutic products based on proprietary delivery systems. They are currently focusing their efforts on new and patented pharmaceutical products based on a penetration enhancement topical delivery technology known as NexACT(R), which may enable an active drug to be better absorbed through the skin.

MP Securities' equity research department provides institutional clients with comprehensive industry knowledge, unique insight and actionable information. JMP's senior research analysts are charged with developing proprietary investment themes, anticipating secular and cyclical changes and producing action-oriented reports. JMP follows companies in six industries that exhibit above-average long-term growth characteristics — Technology, Healthcare, Consumer, Real Estate, Financial Services and Business Services — and produces specialized equity research that enables investors to understand and invest in complicated growth stocks profitably.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/14/2012 10:25 AM Buy
3.04 6.00
as of 12/31/2012
1 Week down  -3.80 %
1 Month down  -8.18 %
3 Months down  -38.03 %
1 YTD down  -33.55 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy